Méndez-Vidal, María José; Molina, Áurea; Anido, Urbano; Chirivella, Isabel; Etxaniz, Olatz; Fernández-Parra, Eva; Guix Arnau, Marta, 1974-; Hernández, Carolina; Lambea, Julio; Montesa, Álvaro; Pinto, Álvaro; Ros, Silverio; Gallardo, Enrique
(BioMed Central, 2018)
BACKGROUND: Pazopanib is indicated in the first-line treatment of metastatic renal cell cancer (mRCC). The aim of this study was to review the efficacy, safety, and pharmacokinetics of pazopanib and see how these aspects ...